|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Shingrix
|
|
gptkbp:affects
|
chronic pain
skin scarring
|
|
gptkbp:age
|
adults
elderly
|
|
gptkbp:associated_with
|
chickenpox
|
|
gptkbp:caused_by
|
gptkb:varicella-zoster_virus
|
|
gptkbp:common_name
|
shingles
|
|
gptkbp:complications
|
postherpetic neuralgia
|
|
gptkbp:current_use
|
gptkb:healthcare_organization
gptkb:HIV/_AIDS
autoimmune diseases
|
|
gptkbp:distribution
|
worldwide
|
|
gptkbp:duration
|
2 to 4 weeks
|
|
gptkbp:education
|
important
|
|
gptkbp:first_described_by
|
gptkb:19th_century
|
|
gptkbp:has_lore
|
only affects older adults
can be transmitted through touch
is the same as chickenpox
|
|
gptkbp:healthcare
|
gptkb:significant
gptkb:battle
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
herpes zoster
|
|
gptkbp:incubation_period
|
2 to 3 weeks
|
|
gptkbp:is_popular_in
|
increases with age
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_vulnerable_to
|
shingles vaccine
zoster vaccine
|
|
gptkbp:research_focus
|
immune response
pain management
vaccine development
|
|
gptkbp:risk_factor
|
low
age
weakened immune system
|
|
gptkbp:social_responsibility
|
clinical evaluation
laboratory tests
|
|
gptkbp:symptoms
|
fatigue
headache
fever
pain
rash
burning sensation
blisters
tingling
|
|
gptkbp:transmission
|
not contagious
|
|
gptkbp:treatment
|
gptkb:skincare_product
gptkb:drug
high if treated early
early treatment recommended
|